BORCS8-MEF2B靶向药基因

基因名称:BORCS8-MEF2B  (BORCS8-MEF2B readthrough)

别名: MEF2B,RSRFR2,MEF2BNB-MEF2B,LOC729991-MEF2B
基因ID:4207
Chromosome(GRCh37) :19 Start: 19256376 End: 19303400 Strand:
信号通路:
靶向药:
化疗药:

简介:这个基因代表了跨越基因id:729991和100271849的大量读写转录本。许多通读转录本被预测为无意义介导衰变(nmd)候选,并且被认为是非编码的。一些转录本被预测能够在下游的AUG处重新启动翻译,从而从该读通位点表达至少一种心肌细胞增强因子2B(MEF2B)的亚型至少一个额外的mef2b变体和亚型可以从下游启动子表达,并在geneid:100271849上注释。[由RefSeq提供,2010年10月]This gene represents numerous read-through transcripts that span GeneID:729991 and 100271849. Many read-through transcripts are predicted to be nonsense-mediated decay (NMD) candidates, and are thought to be non-coding. Some transcripts are predicted to be capable of translation reinitiation at a downstream AUG, resulting in expression of at least one isoform of myocyte enhancer factor 2B (MEF2B) from this read-through locus. At least one additional MEF2B variant and isoform can be expressed from a downstream promoter, and is annotated on GeneID:100271849. [provided by RefSeq, Oct 2010]
BORCS8-MEF2B突变与药物:

常见问题
  • 如何在体龙基因完成所需的检测项目 流程简述 :在线咨询 - 采样送检 - 付款检测 - 检测分析 - 报告结果
查看详情

相关内容

官方客服团队

为您解决烦忧 - 24小时在线 专业服务